Check-Cap (CHEK) - חוב לטווח ארוך להון

Check-Cap Ltd. (CHEK) attracts clients with its non-invasive C-Scan for bowel screening. The long-term financial debt sustainability metric in the GURU.Markets chronology demonstrates that the value remains at 0.00. Israeli centers are developing unique capsule systems for the global market, while outsourcing logistics—while maintaining full control over patents and software—shields the biotech business from dependencies.

Investors seek business stability by analyzing debt load. The uniqueness of the C-Scan system and the inelastic demand for cancer screening create a solid foundation for the development of Check-Cap Ltd. (CHEK). The long-term debt-to-equity ratio reflects the proportion of liabilities with a maturity of over one year relative to equity. A decrease in this metric confirms financial autonomy and the minimization of default risks. Low leverage guarantees the asset's solvency.